Added Scientific.

Bringing Cutting-Edge Research to Additive Manufacturing.

Added Scientific supports organisations wanting to explore the implementation of Additive Manufacturing and digital Printing for the production of their products, and hardware and materials vendors wanting to develop and commercialise their own printing materials and systems.

Technology & Services.

Added Scientific has combined expertise with innovative research and design to provide commercial research and development services for companies keen to push the boundaries of Additive Manufacturing.are experts across polymer, metallic and multi-material 2D and 3D Printing, with particular expertise in material jetting, photo-polymerisation and powder-based technologies, alongside design optimisation, simulation and modelling capability. 

The Market.

The global additive manufacturing market is forecast to reach $26.68 Billion by 2027 with a CAGR of 14.4% and has applications in a wide range of marketing including Aerospace, Medical, Manufacturing, Automotive  and Construction.

Business Model.

Added Scientific provides contract research & development, training and consultancy in Additive Manufacturing and 3D Printing (AM &3DP).

Team.

CEO: Tim Setchfield
Director & Founder: Prof Richard Hague

Contact: [email protected] | https://www.mip-dx.com/

KEY FEATURES.

9C12A659-F601-4D82-B0B7-58B26B8FB50E

Office space

In oculis quidem se esse vult, summumque malum et, quantum.

Lab space

In oculis quidem se esse vult, summumque malum et, quantum.

Business support

In oculis quidem se esse vult, summumque malum et, quantum.

8BA7CC87-ADB9-4E9E-B6B0-0F609EA2D3A9

Meeting rooms

In oculis quidem se esse vult, summumque malum et, quantum.

Virtual tenancy

In oculis quidem se esse vult, summumque malum et, quantum.

Hot desks

In oculis quidem se esse vult, summumque malum et, quantum.

IP Status

In oculis quidem se esse vult, summumque malum et, quantum.

Opportunity

In oculis quidem se esse vult, summumque malum et, quantum.

Application areas

In oculis quidem se esse vult, summumque malum et, quantum.

Management Team

In oculis quidem se esse vult, summumque malum et, quantum.

27D4EAE4-6FBF-4578-BCBD-4F102E515086

Investment Stage

In oculis quidem se esse vult, summumque malum et, quantum.

1EEFF807-B5A2-4190-89BC-DE59BFF00B15

Investors

In oculis quidem se esse vult, summumque malum et, quantum.

Technology Readiness

In oculis quidem se esse vult, summumque malum et, quantum.

Make An Enquiry.